The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant leaf.

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.